KDIGO at the World Congress of Nephrology |
|
This year KDIGO held two sessions, which drew large crowds and sparked insightful discussions. The first session was on Autosomal Dominant Polycystic Kidney Disease (ADPKD), and featured ADPKD Guideline Co-Chair, Vicente Torres, MD (United States), Guideline Work Group Members Peter Harris, MD (United States) and Luiz Onuchic, MD (Brazil), and Ita Pfeferman Heilberg, MD (Brazil). The panel delved into various aspects of ADPKD management, covering topics ranging from optimization of patient care to the role of tolvaptan in hypertension management. The session concluded with a lively question and answer segment.
KDIGO also held a joint session with the ISN, "KDIGO 2024 Anemia Guideline: Case-based Illustrations," with Anemia Guideline Co-Chair Marcello Tonelli, MD (Canada), and Guideline Work Group Members Evi Nagler, MD (Belgium) and José Moura-Neto, MD (Brazil). The session provided invaluable insights into the diagnosis and management of anemia in CKD patients. Attendees were treated to practical applications of the guideline, tailored to various patient populations, including those on dialysis, kidney transplant recipients, and children with CKD. A question and answer segment offered an engaging interactive dialogue.
Beyond the sessions, KDIGO's booth served as a hub of activity, where staff shared resources from the 2024 CKD and Lupus Nephritis Guidelines. KDIGO appreciated the opportunity to connect with new contacts and familiar faces, and eagerly looks forward to WCN 2025 in New Delhi, India.
|
|
KDIGO Releases New CKD Guideline Resources |
|
In Primary Care in CKD: Insights from the KDIGO 2024 CKD Guideline, guideline Work Group Member, Michael Shlipak, MD (United States) shares key insights for primary care physicians (PCPs) from the guideline. This six-part video series covers the burden, detection, and staging of CKD, risk assessment, statins, blood pressure control, RAS inhibitors, and SGLT2 inhibitors.
KDIGO has also created a series of one-pagers that highlight the top ten to twelve takeaways from the CKD Guideline. These are designed for nephrologists, pediatricians, and PCPs. Read the KDIGO CKD Guideline, Executive Summary, and check out the latest resources on the KDIGO CKD Guideline Website.
|
|
Leaving No Stone Unturned: Optimizing Management for Patients with CKD
Wednesday, April 24 at 5:00 PM BST, 12:00 PM EDT
The webinar features an impressive panel of global experts, including KDIGO 2024 CKD Guideline Co-Chair Adeera Levin, MD (Canada), CKD Guideline Work Group Members Magdalena Madero, MD (Mexico), and Rümeyza Kazancıoğlu, MD (Turkey) as well as KDIGO Diabetes Guideline Co-Chair Peter Rossing, MD (Denmark). Register for the next webinar in this important series.
|
|
An Expert Approach to Cardio-Renal Protection in CKD: A Case Based Discussion Parts 1 and 2
On Demand CME Webinars
The first webinar is chaired by Professor James Burton, MD (United Kingdom) with expert insight from a world-renowned faculty David Wheeler, MD (United Kingom), Navdeep Tangri, MD (Canada), and Carol Pollock, MD (Australia). This expert panel unravels the complexities of CKD care in the context of a real-world patient case.
Part two offers a forensic analysis of current practices, revisiting the original patient case in reflection of expected guideline updates. In this webinar, the panel provides evidence-based strategies for initiating pharmacological therapies that transcend the theoretical and become actionable in everyday practice. Watch the webinars.
|
|
Tailored Care: A Push Towards Personalization in the Diagnosis and Prognosis of CKD
On Demand Webinar
|
|
Shared Decision-Making in Kidney Transplantation
On Demand
Do you have questions about kidney failure treatment? Watch Shared Decision-Making in Kidney Transplantation to hear Kevin Fowler interview Nichole Jefferson on how she advocated for the best possible care during her first and second kidney transplants. Nichole shares tips on securing a kidney transplant, including where to get listed, listening to your body, and how to advocate for yourself. Watch this important video and share it with your patients facing kidney transplantation.
|
|
Incorporating Targeted Therapies in Treatment Planning for AAV
On Demand CME Webinar
Available in English and Spanish
ANCA-associated vasculitis (AAV) is a complex autoimmune disease. This condition can lead to life-threatening complications that primarily affect kidney function due to necrotizing glomerulonephritis. In Incorporating Targeted Therapies in Treatment Planning for AAV, Bernhard Hellmich, MD (Germany) and David Jayne, MD (United Kingdom) discuss how to incorporate targeted therapies when managing AAV.
This webinar, developed by Medtelligence and available in Spanish, is designed to meet the educational needs of nephrologists and rheumatologists. After participating in this educational activity, participants should be better able to identify the role of the alternative complement pathway in the pathogenesis of AAV, contrast the efficacy and safety of induction and maintenance therapies in managing patients with AAV, and identify patients who may benefit from C5a inhibitors. Watch the webinar in English or in Spanish.
|
|
About KDIGO
KDIGO is a Belgian foundation committed to developing and implementing nephrology guidelines that improve outcomes for people with kidney disease on a global basis. KDIGO is independent, volunteer-led, self-managed, and accountable to the public and the people it serves. Learn more.
|
|
|
|
|
|
|
